HealthTech Innovations: Building Tech-Infused Healthcare Systems for a Post COVID-19 World

Context and Event Overview

• The 11th episode of the Milken Institute's "The World Post-COVID-19" webinar series focused on health tech innovations and building integrated healthcare systems.
• Moderated by Dr. Jeremy Lim (National University of Singapore), the panel included Jeff Chan (Fullerton Health), Jonathan Larson (Ping'an/Good Doctor), and Ingrid Li (iCarbonX).
• The discussion highlighted the pandemic as a catalytic moment accelerating the acceptance of digital health innovations to support struggling healthcare systems.

Market Growth and User Adoption Trends

• Ping An's Good Doctor platform, launched eight years prior, reached 300 million registered users by the end of 2020 with a market capitalization of approximately $14 billion.
• During the January–February 2020 peak in China, Good Doctor recorded 1.1 billion visits in a three-and-a-half-week period.
• User engagement metrics during the pandemic peak included a 10-fold increase in registered users and a 9-fold increase in daily consultation rates.
• Experts predict a permanent shift in user behavior, driven by the elimination of physical hospital waiting times and departmental shuffling.
• Fullerton Health transitioned from an offline model to an integrated online-to-offline model following a surge in demand during Singapore's circuit breaker lockdowns in February/March.

Regulatory and Financial Shifts

• Hubei province (Wuhan, the original epicenter) began reimbursing telemedicine consultations, marking a watershed moment in a state-driven system where state insurance previously covered zero telehealth expenses.
• This reimbursement shift is expected to expand nationally, aligning with the Chinese government's plan to integrate telehealth into the national health infrastructure.
• Healthcare spending disparities were noted: China spends approximately $700 annually per capita compared to $11,000 in the US and $4,000 in Germany, UK, Australia, and Japan.
• Experts argue that China cannot afford to replicate the high-cost Western model and must rely on technology to calibrate its system to global standards.
• Traditional private-insured markets like Singapore are seeing increased payer adoption of telehealth due to pandemic-driven demand, contrasting with previous low adoption rates.

Technological Innovations and Applications

• Point-of-Care Diagnostics: Emerging technologies include low-cost handheld devices capable of performing viral identification and blood tests with results in 10–20 minutes.
• AI Diagnostic Imaging: Investment in AirDoc demonstrates AI's ability to identify 30 disease types from single retinal scans and detect lung cancers via X-ray/CT visual analysis.
• Digital Triage and Workflow: Platforms like Good Doctor utilize automated AI triage layers to provide provisional diagnoses, while final confirmation remains with human doctors.
• Remote Examination Tools: Innovations include digital stethoscopes, temperature monitors, and cameras to simulate in-person examinations virtually.
• Proactive Health Management: iCarbonX advocates for a shift from reactive treatment to proactive health preservation using multi-dimensional profiles (genetics, biochemistry, biophysics) to predict medical events.

Operational Challenges and Solutions

• Doctor Adoption: Fullerton Health mitigated doctor resistance by rotating virtual consult duties (1–2 hours/day) rather than mandating full-time virtual sessions, showing efficiency gains.
• Efficiency Metrics: Implementation of digital symptom collectors reduced patient wait times from 1.5–2 hours in clinics to an average of 8 minutes for virtual appointments.
• Data Silos: The industry currently suffers from deep silos; proposed solutions involve shifting record ownership to the individual, making patient data portable and secure.
• Explainability vs. AI: Experts noted the challenge of "black box" AI decision-making; the proposed solution is using AI to provide evidence-based support to doctors rather than replacing doctor decision-making.
• Real-World Evidence: Large-scale community tracking (e.g., 400,000 people) is being used to validate AI predictions through real-world cohort studies and long-term outcome tracking.

Future Outlook and Strategic Recommendations

• Unlike the SARS outbreak which lasted four months, COVID-19 is expected to persist, requiring long-term digital infrastructure rather than temporary fixes.
• Transformation requires a collaborative strategy involving government leadership, payers, traditional providers, and new digital-native entities.
• Mobile ubiquity, cloud computing, and advanced processing power on devices are now enabling digital health models that were previously impractical.
• Telemedicine infrastructure has the potential to evolve into the backbone of the health system, serving as a secure, patient-controlled locus for individual health records and population health data.
• The Milken Institute plans to pause the series and resume in July with a new focus on US-China relations and ESG issues.